Ophthalmology · Neuro-ophthalmology
The facts most likely to be tested
Optic neuritis presents as acute, unilateral vision loss accompanied by pain with extraocular movements.
The most common underlying systemic association is Multiple Sclerosis (MS), often serving as the initial presenting symptom.
Physical examination reveals an afferent pupillary defect (Marcus Gunn pupil) and a swollen optic disc (papillitis) in one-third of cases.
Color vision is disproportionately affected, specifically manifesting as dyschromatopsia (impaired red color desaturation).
The gold standard diagnostic imaging modality is MRI of the brain and orbits with gadolinium contrast to identify demyelinating plaques.
First-line treatment for acute, symptomatic optic neuritis is high-dose intravenous methylprednisolone to accelerate visual recovery.
Visual prognosis is generally favorable, but patients remain at high risk for the development of clinically definite Multiple Sclerosis over the following decade.
Vignette unlocked
A 28-year-old woman presents to the clinic complaining of a 3-day history of progressive vision loss in her right eye. She describes the vision as 'dim' and notes that colors appear washed out, particularly the color red. She reports significant pain with eye movement. On physical exam, she has a right-sided afferent pupillary defect. Funduscopic examination reveals a swollen optic disc in the right eye.
What is the most appropriate next step in the management of this patient?
MRI of the brain and orbits with gadolinium contrast
The patient's presentation of unilateral vision loss, pain with eye movement, and an afferent pupillary defect is classic for optic neuritis; MRI is required to evaluate for demyelinating lesions suggestive of Multiple Sclerosis.
Full handout
High yield triage
Etiology / Epidemiology
Strongly associated with Multiple Sclerosis; most common in females aged 20-40.
Clinical Manifestations
Acute unilateral vision loss with pain with eye movement and afferent pupillary defect.
Diagnosis
Clinical diagnosis; MRI of the brain and orbits is the gold standard to assess MS risk.
Treatment
IV methylprednisolone is first-line; do not use oral steroids alone.
Prognosis
Most patients recover vision within 2-6 weeks; high risk of developing Multiple Sclerosis.
Full handout
Epidemiology & Etiology
Most frequently presents in young adults, particularly women, as the initial manifestation of multiple sclerosis. Other etiologies include autoimmune conditions, infections like syphilis or Lyme disease, and medication-induced toxicity. Multiple Sclerosis is the primary underlying concern in clinical practice.
Pertinent Anatomy
Inflammation occurs in the optic nerve (cranial nerve II), which transmits visual information from the retina to the brain. The optic disc may appear swollen (papillitis) or normal (retrobulbar neuritis) depending on the location of the lesion.
Pathophysiology
The process involves demyelination of the optic nerve fibers, leading to impaired signal conduction. This inflammatory cascade results in acute visual field defects and color vision disturbances. Chronic inflammation can lead to optic nerve atrophy and permanent visual impairment.
Clinical Manifestations
Patients report acute, often painful, monocular vision loss that worsens with eye movement. A hallmark finding is the Marcus Gunn pupil (relative afferent pupillary defect). Patients often describe color desaturation, specifically difficulty perceiving red hues. Red flags include bilateral involvement or lack of pain, which should prompt investigation for alternative etiologies.
Diagnosis
Diagnosis is primarily clinical, focusing on the presence of an afferent pupillary defect and visual field testing. MRI of the brain and orbits with gadolinium contrast is the gold standard to identify demyelinating plaques. Lumbar puncture may be indicated if atypical features are present to rule out infectious or inflammatory mimics.
Treatment
High-dose IV methylprednisolone is the standard of care to accelerate visual recovery. Oral prednisone is contraindicated as monotherapy because it has been shown to increase the rate of recurrence. If vision does not improve, plasma exchange or IVIG may be considered in refractory cases.
Prognosis
Visual acuity typically improves significantly within 2-6 weeks even without treatment. Long-term management focuses on monitoring for the development of Multiple Sclerosis, with a 15-year risk of conversion reaching approximately 50% in patients with abnormal MRI findings.
Differential Diagnosis
Anterior Ischemic Optic Neuropathy: typically painless and occurs in older patients with vascular risk factors
Papilledema: bilateral disc swelling due to increased intracranial pressure, usually with preserved visual acuity
Leber Hereditary Optic Neuropathy: painless, sequential bilateral vision loss, usually in young males
Toxic/Nutritional Optic Neuropathy: usually bilateral, painless, and slowly progressive
Orbital Cellulitis: associated with fever, proptosis, and restricted extraocular movements